Detalhe da pesquisa
1.
Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group.
J Eur Acad Dermatol Venereol
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581201
2.
The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
Br J Dermatol
; 185(1): 19-25, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33155285
3.
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
Br J Dermatol
; 184(3): 524-531, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32574377
4.
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial.
J Eur Acad Dermatol Venereol
; 35(11): 2225-2238, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273208
5.
The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
Br J Dermatol
; 181(2): 350-357, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30267549
6.
Real-world experience of using mogamulizumab in relapsed/refractory mycosis fungoides/Sézary syndrome.
Br J Dermatol
; 184(5): 978-981, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314065
7.
Brentuximab a novel antibody therapy: real-world use confirms efficacy and tolerability for CD30-positive cutaneous lymphoma.
Br J Dermatol
; 182(3): 799-800, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31529492
8.
Evaluation of haematopoietic stem cell transplantation in patients diagnosed with cutaneous T-cell lymphoma at a tertiary care centre: should we avoid chemotherapy in conditioning regimes?
Br J Dermatol
; 182(3): 807-809, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31536644
9.
Ethnicity in mycosis fungoides: white patients present at an older age and with more advanced disease.
Br J Dermatol
; 180(5): 1264-1265, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30604865
10.
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Br J Dermatol
; 170(6): 1226-36, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24641480
11.
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018.
Br J Dermatol
; 180(3): 496-526, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561020
12.
How big is your hand and should you use it to score skin in cutaneous T-cell lymphoma?
Br J Dermatol
; 169(2): 260-5, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23621659
13.
U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma.
Br J Dermatol
; 168(1): 192-200, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22963233
14.
Prognostic factors in mycosis fungoides: international advances in the validation of prognostic indices.
Br J Dermatol
; 176(5): 1129-1130, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28504404
15.
Brentuximab vedotin is an effective therapy for CD30+ mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?
Br J Dermatol
; 177(6): 1474-1475, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29313932
16.
Image Gallery: Secondary cutaneous involvement of the ear with systemic small lymphocytic lymphoma: a rare manifestation.
Br J Dermatol
; 177(2): e26, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28833023
17.
Primary cutaneous B-cell lymphoma: systemic spread is rare while cutaneous relapses and secondary malignancies are frequent.
Br J Dermatol
; 177(1): 287-289, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641754
18.
The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomas.
Presse Med
; 51(1): 104123, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35490911
19.
Cutaneous T-cell lymphomas: an urgent need for more improved therapies.
Br J Dermatol
; 175(1): 14-5, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27484267
20.
Unmasking mycosis fungoides/Sézary syndrome from preceding or co-existing benign inflammatory dermatoses requiring systemic therapies: patients frequently present with advanced disease and have an aggressive clinical course.
Br J Dermatol
; 174(4): 901-4, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26479768